← Back to Institution Rankings

MultiMedica

Microplastic research output and top contributors from MultiMedica.

🇮🇹 healthcare
15
Papers
0
Tier 1 Papers
115
Citations
100% of papers are collaborative — co-authored with researchers from other institutions. Only 0 papers list MultiMedica as the sole institution. How attribution works →

Publication Trend

Top Authors

showing 16 of 21 View all →
Author Papers
Francesco Prattichizzo 4
Valeria Pellegrini 4
Antonio Ceriello 4
Rosalba La Grotta 3
Francesco Prattichizzo 3
Antonio Ceriello 3
Paolo Magni 2
Antonio Ceriello 2
Francesco Prattichizzo 1
Angelo Fenti 1
Valeria Pellegrini 1
Valeria Pellegrini 1
Francesco Prattichizzo 1
Francesca Carreras 1
Francesco Prattichizzo 1
Carmine Pizzi 1

Top Papers

top 13 of 15 by citations Browse all →
Micro-nanoplastics and cardiovascular diseases: evidence and perspectives
2024 Tier 2 88 citations
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors
2024 Tier 2 14 citations
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
2025 Tier 11 citations
Microplastics and Atherosclerosis: Mechanisms
2026 Tier 2 1 citations
Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation
2026 Tier 2 1 citations
Additional file 1 of PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation
2026 Tier 2
PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation
2026 Tier 2
Additional file 1 of PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation
2026 Tier 2
PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation
2026 Tier 2
PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation
2025 Tier 2
Microplastics and nanoplastics: tiny threats for cardiovascular diseases?
2025 Tier 2
Cytotoxic and dysmetabolic impact of polystyrene nanoplastics, a new potential atherosclerotic cardiovascular risk factor, on a steatosis model of HepG2 cells
2025 Tier 2
Nanoplastic-induced cytotoxic and dysmetabolic effects in a steatosis-like model of HepG2 cells
2024 Tier 2